MARKET

NAUT

NAUT

Nautilus Biotechnology Inc
NASDAQ
0.7000
-0.0145
-2.03%
After Hours: 0.7000 0 0.00% 16:00 05/09 EDT
OPEN
0.7100
PREV CLOSE
0.7145
HIGH
0.7145
LOW
0.6975
VOLUME
105.79K
TURNOVER
--
52 WEEK HIGH
3.090
52 WEEK LOW
0.6600
MARKET CAP
88.30M
P/E (TTM)
-1.2811
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NAUT last week (0428-0502)?
Weekly Report · 6d ago
Guggenheim Sticks to Their Buy Rating for Nautilus Biotechnolgy (NAUT)
TipRanks · 04/30 12:25
Nautilus Biotechnology Reports Q1 2025 Financial Results
TipRanks · 04/30 04:48
Nautilus Biotech’s Earnings Call Highlights Progress and Promise
TipRanks · 04/30 00:34
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pfizer (PFE) and Nautilus Biotechnolgy (NAUT)
TipRanks · 04/29 21:20
Nautilus Biotechnology targets late 2026 platform launch amid proteoform assay advancements
Seeking Alpha · 04/29 17:01
Nautilus Biotechnology Inc reports results for the quarter ended March 31 - Earnings Summary
Reuters · 04/29 13:31
Nautilus Biotechnology reports Q1 EPS (13c), consensus (14c)
TipRanks · 04/29 12:05
More
About NAUT
More
Nautilus Biotechnology, Inc. is a development stage life sciences company. The Company is engaged in creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company is focused on transforming the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. The Company's platform end-to-end solution comprised of the proteome analysis system, consumables, and software. The Company’s products include Proteome Analysis System, and Reagent Kits. Its proteome analysis system is a high-resolution optical imaging system coupled with integrated fluidics and liquid handling sub-systems. The Company’s Reagent Kits are comprised of four main components: sample preparation, flow cell(s), multi-affinity probe reagents, and instrument buffers used to perform multi-cycle analysis runs.
Recently
Symbol
Price
%Change

Webull offers Nautilus Biotechnology Inc stock information, including NASDAQ: NAUT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAUT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAUT stock methods without spending real money on the virtual paper trading platform.